Welcome to pharmacology by Lecturio. I'm Dr. Pravin Shukle.
We're going to be covering GI pharmacology today.
The drugs used for gastrointestinal order
spend a huge range of medications.
We have drugs for peptic acid disease, drugs for pro-motility,
drugs for irritable bowel disease,
drugs for inflammatory bowel disease, and anti-emetics.
We have a whole host of other agents as well for various elements.
Let's look at peptic acid disease. We have the antacids, the H2
blockers, the PPIs, the mucosal protective agents, and the antibiotics.
Let's start off with the antacids. Now, antacids are weak bases
that neutralize the low pH environment of the stomach.
These can include many agents such as magnesium hydroxide
which is better known as Milk of Magnesia.
Milk of Magnesia is a mainstay of antacid therapy and
it's probably the first line agent that we use in most cases.
It has a strong laxative effects so it's very good
for patients who are also constipated.
Another agent that we use is aluminum hydroxide,
commonly known as Maalox.
It has a strong constipating effects
so it's better for people who have diarrhoea.
And calcium carbonate and sodium bicarbonate
are just plain antacids.
They are absorbed by the gut unlike the other agents.
The first two agents that I mentioned tend to stay in the gut,
these agents are actually get absorbed.
Let's move on to the H2 receptor antagonists. These agents
block histamine at the H2 receptor inside the gastric mucosa,
specifically the parietal cells. You can see that they inhibit
stomach acid production directly, especially at night,
so this is a particularly good agent
for people who have night time GERD symptoms.
They are relatively nontoxic agents, they are actually sold
over the counter now, we don't even prescribe them.
Higher doses last longer.
So taking 300 mg of ranitidine once a day
will give better night time protection even if you
take it in the morning than will 150 mg.
Cimetidine was the original and
prototypical drug in this drug class.
But we actually don't use it because there are multitude of
drug interactions that we get from this particular medication.
Interestingly enough, some of these agents, in particular
cimetidine, do have an antiandrogen effect as well at high doses.
These are the agents that are commonly sold.
Ranitidin, famotidine, these agents are sold over the counter.
They're extensively used all around the world.
Let's move on to the PPIs or the proton pump inhibitors.
These are lipophilic weak bases.
So the agents themselves are not antacids. What they do is they
become protonated, and they work inside the parietal cells
and they get concentrated in these areas up to 1,000 times.
They irreversibly inactivate the
What this does is that it ends up causing
less acid secretion, substantially less.
Now they are rapidly metabolized. They may take 3 to 4 days
to actually have an effect because of this reason.
They are far more effective than the H2 antagonists
that I spoke about earlier
but they last, and they work well,
and they are the mainstay of anti-ulcer therapy.
There are some toxicity issues associated with the PPIs.
You can get diarrhoea, abdominal pain and headache.
And you can get hypergastrinemia
if you use them for a long time.
They may also decrease the ability of drugs
that require higher acid levels, so for example,
ketoconazole requires a high acid environment within
the stomach to become particularly activated and absorbed,
if you give a PPI the same time as you give ketoconazole,
you're going to reduce the availability of ketoconazole to the body
for it to do its job.
The same thing will happen with drugs like digoxin.
Now, a small increase in respiratory and enteric infections
are associated with PPI use.
We have many brands out on the market today,
prototypical drug is omeprazole,
but you have a whole list of other ones
that I've given you here.
Let's move on to the mucosal protective agents.
Now the prototypical example of this is sucralfate.
It's a very poorly soluble molecule.
It polymerizes inside the stomach.
And when I say polymerize what I mean is
is that it forms chains of molecules.
This polymer will bind to the injured tissue
inside the patient stomach.
And it forms a protective coating over those ulcers
and prevents further damage from occuring.
The down side of this medication is
it has to be taken 4 times a day.
And that's really the main reason why we don't use it
as much as we used to, simply because of the inconvenience.
It's a very low toxicity agent. It has a very low solubility.
It's quite effective, unfortunately it's inconvenient.
These medications are great for patients
who are very adherent to their schedule
and so if you know these patients are going to
follow their instructions, it's a great choice.
Let's move on to other agents.
Misoprostol is an analogue of prostaglandin E.
It works at almost the same point in the system as the PPIs.
You get increased mucosal protection
because it directly inhibits acid secretion.
And it reduces ulcers in NSAID users as well.
The adverse event rate is quite high because it's poorly tolerated.
There's lots of GI upset and diarrhoea associated with this agent.
And for this particular reason,
it's not used much anymore.
It is an agent however that you should be aware of because
it is going to be on pharmacology portion of your exam.
Let's move on to agents like colloidal bismuth.
So, bismuth subsalicylate, also called Pepto-Bismol,
gives a protecting coating on ulcerated tissue much like
sucralfate. It stimulates mucosal protective systems as well
so it goes a little bit further than sucralfate in that sense.
It actually has direct antimicrobial effects.
And you actually have some sequestration of enterotoxins.
So if there are toxins within the gut, it actually binds those toxins
and rendor them biologically unavailable.
It reduces stool frequency in infectious diarrhoea.
And unfortunately, there is a cosmetic side effect
of this medication, it causes a black tongue.
Now the other important issue that you have to remember
is it also causes black stools.
And many times, people who have melena type stools from
Pepto-Bismol are misdiagnosed as having GI bleeds.
That is not the case. So be aware that
if you have a patient who presents with melena type stools
as first if they were taking this agent.